Meenal Datta receives 2024 Cellular and Molecular Bioengineering Young Innovator Award
Meenal Datta, assistant professor of aerospace and mechanical engineering, has received a Cellular and Molecular Bioengineering Young Innovator Award. The award, given by the journal of the Biomedical Engineering Society (BMES), recognizes 12 “rising stars” in the field of biomedical engineering each year.
Datta’s research focuses on deciphering the atypical tumor microenvironment that drives disease progression and treatment resistance in incurable cancers such as brain tumors. She also researches the relationship between immune cells and physical forces in the body, and her lab performs health science in space (e.g., in the microgravity environment of the International Space Station) to benefit patients on earth.
Award-recipients contribute a full-length research article to the journal’s Young Innovators Special Issue and are invited to present their work in a platform session at the annual BMES Conference.
At this year’s conference, held on October 23–26, 2024, in Baltimore, Datta presented her research on the ways in which immune cells and physical forces interact in new 3D cell-based models. Datta’s graduate student Alice Burchett is the first author of the study. Datta also presented on recent work to repurpose cancer therapies to improve the treatment of tuberculosis.
Datta teaches in the Notre Dame Bioengineering Graduate Program, the Materials Science and Engineering doctoral program, and in Aerospace and Mechanical Engineering and Chemical and Biomolecular Engineering (concurrent appointment). She joined the Notre Dame faculty in 2021.
Originally published by timelab.nd.edu on October 29, 2024.
atLatest Research
- Biseach Symposium Strengthens Cancer Research Partnership Between Notre Dame and University of Galway…
- Notre Dame announces new research collaborations with Ukrainian Catholic UniversitySeven faculty teams of collaborators from the University of Notre Dame (South Bend, Indiana, USA) and Ukrainian Catholic University (Lviv, Ukraine) have received grants from Notre Dame Global and Notre Dame Research to pursue…
- From reaction to resolution: The future of allergy treatmentTwelve-year-old Lauren Eglite was thrilled to attend a Notre Dame football game with her father, Erik, in 2017, even though her acute peanut allergy demands constant vigilance. She was even more excited when the stadium’s brand-new video board aired an NBC Fighting…
- New Study Highlights Mother-Child Link for Anemia in The GambiaAnemia is a "silent epidemic." It affects nearly 2 billion people globally, yet many people ignore its symptoms. Typically caused by the consumption of iron-deficient foods, anemia develops gradually. Its symptoms—such as fatigue, weakness, and shortness of breath—are frequently dismissed or misattributed.
- Megan McDermott joins ND–IBM Tech Ethics Lab as new Notre Dame directorThe Notre Dame–IBM Technology Ethics Lab, a critical component of the Institute for Ethics and the Common Good (ECG) and the Notre…
- Jenkins Center for Virtue Ethics receives grant to advance love-based ethical frameworkThe University of Notre Dame has received a $10 million grant from the John Templeton Foundation to support a project titled Love and Social Transformation: Empowering Scholars and Social Innovators to Develop the Love Ethic.